Trade Info : Corona Remedies announces dividend and upcoming annual meeting

Symbol

CORONA

Company

Corona Remedies Ltd

Category

Dividend

Source

Stock Exchange Filing

July 9, 2026

www.coronaremedies.com

News Summary

Corona Remedies Limited is holding its 22nd Annual General Meeting on July 9, 2026.
The company has proposed a dividend of 10 rupees per share for the financial year ending March 31, 2026.
Shareholders who have not registered their email addresses are receiving this notice via mail.

Why This Matters

This means the company plans to return a portion of its profits to shareholders.
As a result, investors who approve the dividend will receive cash payments.
Investors should know to update their bank and email details to receive the money electronically.

Fundamental Backdrop (FY 2025 – FY 2026)

Metric	Value
Proposed Dividend Per Share	10 rupees
Meeting Date	July 9, 2026
Meeting Time	11:00 A.M. IST
Meeting Mode	Video Conferencing

Analyst's View

This suggests the company is maintaining a consistent policy of returning profits to owners.
The company appears to be compliant with all regulatory requirements for shareholder communication.
Investors may want to verify their KYC details to ensure they receive the dividend without issues.

Buy

Confidence 85%

Conviction Level 85%

The company is distributing profits and keeping its shareholders informed about important meetings.

Key Positives

The company is paying a dividend of 10 rupees per share.
The annual general meeting is scheduled for July 9, 2026.
The company is complying with all regulatory requirements for shareholder communication.

Key Risks

Dividend payments are subject to approval by shareholders at the annual meeting.
Shareholders who do not update their KYC details may miss out on receiving the dividend.

Horizonmedium term

Confidence LevelHigh

Suggested position size: Maintain current holdings

⚠️

Disclaimer This analysis is for informational purposes only and does not constitute financial advice. Do your own research and consult a qualified financial professional before making any investment decisions.